Truvada Atripla HIV Drugs Settlement: Check If You Are Eligible To File A Claim
Did you receive the Truvada Atripla HIV Drugs Settlement email? It is not a scam. You received the mail because you filed a claim.
Gilead Sciences, the big shot in the world of healthcare and those HIV drugs like Truvada and Atripla, is dishing out a hefty $246.75 million to settle a nationwide class action lawsuit.
So, what’s the scoop here? Well, the accusations were flying that Gilead made folks who bought these HIV meds and their generic versions pay more than they should have.
Who Is Eligible For The Truvada Atripla HIV Drugs Settlement
Well, it’s not just individual folks getting in on this action; we’re talking about a whole class of entities here. These are the ones who directly bought Truvada, Atripla, or their generic versions straight from the manufacturers, and this went down between February 1, 2018, and September 27, 2022. Think wholesale retailers and the like – they’re the main players in this game.
Now, why all the fuss? Gilead was hit with a lawsuit claiming they were doing some not-so-cool things that violated federal antitrust laws. Specifically, they were accused of stifling competition for HIV antiretroviral drugs.
And it’s not just Gilead in the hot seat – Bristol-Meyers Squibb Co. had its own piece of the pie in this lawsuit, but they’ve already settled their part with KPH Healthcare Services.
How Much Is The Settlement
If you’re one of those direct purchasers we talked about earlier, here’s the deal: you can join in on this settlement action by filling out a form. It’s your ticket to potentially get a piece of that $246.75 million pie.
But here’s the catch: if too many folks in the proposed class decide to sit this one out and opt out, that big settlement fund might take a hit. So, if you’re eligible and want in, make sure you don’t miss the boat.
And if you’ve got any objections or issues with the settlement agreement, you’ve got until December 28, 2023.
How To File A Claim
If you are eligible, fill out a valid claim form before the deadline on Jan. 1, 2024. Click here to fill out a form.
Conclusion
KPH Healthcare Services Inc. a/k/a Kinney Drugs Inc. v. Gilead Sciences Inc., et al., Case No. 3:20-cv-06961-EMC is not a scam. Just like Journey’s unsolicited text message settlemen Well, it’s not just individual folks getting in on this action; we’re talking about a whole class of entities here. These are the ones who directly bought Truvada, Atripla, or their generic versions straight from the manufacturers, and this went down between February 1, 2018, and September 27, 2022. Think wholesale retailers and the like – they’re the main players in this game.
